AbbVie
ABBV
#26
Rank
โ‚ฌ343.19 B
Marketcap
194,18ย โ‚ฌ
Share price
-1.15%
Change (1 day)
19.65%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of September 2025 : โ‚ฌ4.87 Billion

According to AbbVie's latest financial reports the company has โ‚ฌ4.87 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚ฌ5.33 B-53.95%
2023-12-31โ‚ฌ11.59 B34.75%
2022-12-31โ‚ฌ8.60 B-0.88%
2021-12-31โ‚ฌ8.67 B25.91%
2020-12-31โ‚ฌ6.89 B-80.66%
2019-12-31โ‚ฌ35.63 B405.78%
2018-12-31โ‚ฌ7.04 B-13.63%
2017-12-31โ‚ฌ8.15 B33.61%
2016-12-31โ‚ฌ6.10 B-20.58%
2015-12-31โ‚ฌ7.68 B11.67%
2014-12-31โ‚ฌ6.88 B-3.9%
2013-12-31โ‚ฌ7.16 B18.83%
2012-12-31โ‚ฌ6.02 B1099.17%
2011-12-31โ‚ฌ0.50 B6107.2%
2010-12-31โ‚ฌ8.1 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
โ‚ฌ12.86 B 164.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ14.17 B 190.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ8.51 B 74.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.11 B 66.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ6.31 B 29.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ3.40 B-30.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ3.81 B-21.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
โ‚ฌ7.02 B 44.28%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ0.95 B-80.34%๐Ÿ‡บ๐Ÿ‡ธ USA